Postchallenge Plasma Glucose and Glycemic Spikes Are Associated with Pulse Pressure in Patients with Impaired Glucose Tolerance and Essential Hypertension

被引:0
作者
Futoshi Anan
Takayuki Masaki
Takeshi Eto
Naoya Fukunaga
Tetsu Iwao
Koji Kaneda
Nobuoki Eshima
Tetsunori Saikawa
Hironobu Yoshimatsu
机构
[1] Oita University,First Department of Internal Medicine
[2] Oita Red Cross Hospital,Department of Cardiology
[3] Oita University,Department of Biostatistics
[4] Faculty of Medicine,Department of Cardiovascular Science
[5] Oita University,undefined
来源
Hypertension Research | 2008年 / 31卷
关键词
pulse pressure; left ventricular mass index; post-challenge glucose spikes; impaired glucose tolerance; essential hypertension;
D O I
暂无
中图分类号
学科分类号
摘要
Elevated pulse pressure (PP) is associated with an increased risk of cardiovascular events. We examined whether PP is associated with post-challenge hyperglycemia in Japanese patients with essential hypertension and impaired glucose tolerance (IGT). In a total of 70 untreated essential hypertensive patients (age: 57±4 years, mean±SD; males±35, females=35), 24-h ambulatory blood pressure (ABP) monitoring, 75 g oral glucose tolerance testing (OGTT), metabolic analysis and echocardiography were performed. Patients were categorized into a high PP group (PP≥60 mmHg, n≥33) or a normal PP group (PP<60 mmHg, n=37). In all patients, 24-h systolic ABP, daytime systolic ABP, nighttime systolic ABP, and nighttime heart rate were significantly higher in the high PP group. Additionally, fasting immunoreactive insulin (F-IRI), homeostasis model assessment (HOMA) index, left ventricular mass index (LVMI) were also elevated in the high PP group. Finally, the high PP group exhibited impaired insulin secretion, increased post-challenge glucose concentrations and greater glucose spikes (PGS) during 75 g OGTT. Of the parameters measured, 24-h PP correlated positively with age, triglyceride, uric acid, F-IRI, HOMA index, 1-h postload glucose and insulin, 2-h postload glucose and insulin, PGS60, PGS120, PGSmax, LVMI, and deceleration time but correlated negatively with HDL-cholesterol and E/A ratio. Multiple regression analysis revealed that PP level was independently predicted by age, LVMI, and PGS120. Our results show that age, LVMI, and PGS120 are significantly associated with high PP in Japanese patients with IGT and essential hypertension.
引用
收藏
页码:1565 / 1571
页数:6
相关论文
共 163 条
  • [11] Rudnichi A(1998)Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study Diabetes Care 21 1236-1239
  • [12] Benetos A(1999)Impaired glucose tolerance is a risk fator for cardiovascular disease, but not in impaired fasting glucose. The Funagata Diabetes Study Diabetes Care 22 920-924
  • [13] Rudnichi A(2000)Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose and HbA1c level Diabetes Care 23 1830-1834
  • [14] Safar M(2000)Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans Diabetes Care 23 465-471
  • [15] Guize L(1996)Ad Hoc Panel: Recommendations for the use of home (self) and ambulatory blood pressure monitoring Am J Hypertens 9 1-11
  • [16] Fang J(1996)Effect of insufficient sleep on blood pressure monitored by a new multibiomedical recorder Hypertension 27 1318-1324
  • [17] Madhavan S(1995)Autonomic nervous function in non-dipper essential hypertensive subjects. Evaluation by power spectral analysis of heart rate variability Hypertension 26 808-814
  • [18] Alderman MH(1986)Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings Am J Cardiol 57 450-458
  • [19] Saloman V(2003)ST-segment depression in hypertensive patients is linked to elevations in blood pressure, pulse pressure and double product by 24-h Cardiotens monitoring J Hypertens 21 977-983
  • [20] Riley W(1985)Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412-419